Publication | Closed Access

Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer

Breast OncologyOncologyReal-world ExperienceMedicineCancer ManagementGynecologyPalbociclib-induced Adverse EventsBreast CancerPharmacotherapyPharmacologyRadiation OncologyEndocrine-related CancerWomen's Health